Advertisement
Letter| Volume 21, ISSUE 2, P262, March 2022

Response to letter to the editor

  • William Small Jr
    Correspondence
    Corresponding author. Loyola University Chicago, Loyola University Medical Center, Stritch School of Medicine, Department of Radiation Oncology, Cardinal Bernardin Cancer Center, Maywood, IL
    Affiliations
    Loyola University Chicago, Loyola University Medical Center, Stritch School of Medicine, Department of Radiation Oncology, Cardinal Bernardin Cancer Center, Maywood, IL
    Search for articles by this author
Published:January 07, 2022DOI:https://doi.org/10.1016/j.brachy.2021.11.005
      I want to thank Drs. Sapienza, Ludwig, and Baiocchi for their thoughtful letter regarding our article relating to uterine perforation (
      • Small Jr., W.
      • Kim YS
      • Joyce C
      Uterine perforation during brachytherapy for cervical cancer: complications, outcomes, and best practices for forward treatment planning and management.
      ). I do agree that the results of the study suggest that uterine perforation is not generally a reason to avoid proceeding with a brachytherapy implant. The results of the study do note that ultrasound guidance was not associated with an improvement in the incidence of uterine perforation. This is in contrast to multiple studies, including a study I published, suggesting that a uterine tandem should never be placed without guidance (
      • Pareek V.
      • Barthwal M.
      • Giridhar P.
      • et al.
      A phase III randomized trial of transabdominal ultrasound in improving application quality and dosimetry of intra-cavitary brachytherapy in locally advanced cervical cancer.
      ,
      • Sapienza L.G.
      • Jhingran A.
      • Kollmeier M.A.
      • et al.
      Decrease in uterine perforations with ultrasound image-guided applicator insertion in intracavitary brachytherapy for cervical cancer: a systematic review and meta-analysis.
      ,
      • Bayrak M.
      • Abakay C.D.
      Prevention of uterine perforation during intracavitary brachytherapy of cervical cancer.
      ,
      • Chino J.
      • Annunziata C.M.
      • Beriwal S.
      • et al.
      Radiation therapy for cervical cancer: executive summary of an ASTRO clinical practice guideline.
      • Small Jr., W.
      • Strauss JB.
      • Hwang CS
      • et al.
      Should uterine tandem applicators ever be placed without ultrasound guidance? No: a brief report and review of the literature.
      ). The authors correctly point out that we did not evaluate the risk of uterine perforation with or without the use of ultrasound guidance in relationship to changes in procedures – specifically the discontinuation of the use of a smit sleeve. The patients that had 1–2 implants had a statistically higher rate of perforations compared to 5−6 implants (p = 0.009). In general, the 5−6 implants were associated with the use of a smit sleeve. I agree with the suggestion that the terminology could be better refined to report the precise timing that the image was performed, using subcategories of "real-time image guided" (if the US image is obtained simultaneously with the progression of the tandem through the cervix) and "real time image-assisted" (if the US image was done only in time points immediately before and/or after insertion to provide anatomic information and confirmation of the placement). We currently use real-time ultrasound image guidance with all our implants.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Brachytherapy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Small Jr., W.
        • Kim YS
        • Joyce C
        Uterine perforation during brachytherapy for cervical cancer: complications, outcomes, and best practices for forward treatment planning and management.
        Brachytherapy. 2021; 20: 557-564
        • Pareek V.
        • Barthwal M.
        • Giridhar P.
        • et al.
        A phase III randomized trial of transabdominal ultrasound in improving application quality and dosimetry of intra-cavitary brachytherapy in locally advanced cervical cancer.
        Gynecol Oncol. 2021; 160: 375-378
        • Sapienza L.G.
        • Jhingran A.
        • Kollmeier M.A.
        • et al.
        Decrease in uterine perforations with ultrasound image-guided applicator insertion in intracavitary brachytherapy for cervical cancer: a systematic review and meta-analysis.
        Gynecol Oncol. 2018; 151: 573-578
        • Bayrak M.
        • Abakay C.D.
        Prevention of uterine perforation during intracavitary brachytherapy of cervical cancer.
        J Contemp Brachytherapy. 2021; 13: 167-171
        • Chino J.
        • Annunziata C.M.
        • Beriwal S.
        • et al.
        Radiation therapy for cervical cancer: executive summary of an ASTRO clinical practice guideline.
        Pract Radiat Oncol. 2020; 10: 220-234
        • Small Jr., W.
        • Strauss JB.
        • Hwang CS
        • et al.
        Should uterine tandem applicators ever be placed without ultrasound guidance? No: a brief report and review of the literature.
        Int J Gynecol Cancer. 2011; 21: 941-944
        • Damato A.L.
        • Viswanathan A.N.
        Magnetic resonance-guided gynecologic brachytherapy.
        Magn Reson Imaging Clin N Am. 2015; 23: 633-642